Red light (670nm) treatment to prevent retinopathy of prematurity (ROP)

Phase 2

Completed

• Conditions: Retinopathy of prematurity; Chronic Lung Disease; Eye - Diseases / disorders of the eye; Respiratory - Normal development and function of the respiratory system

• Registration Number: ACTRN12612001257853
• Lead Sponsor: Canberra Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-11-29
• Study Completion: 2014-02-14
• Last Update Posted: 3 March 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

Premature neonates less than 30 weeks gestation or less than 1150 grams birthweight
Informed consent obtained in the first 24-48 hours of life

Exclusion Criteria

Significant chromosomal or congenital anomalies

Study & Design

• Study Type: Interventional
• Study Design: Not specified